Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments.
OBJECTIVE
Radiotherapy (RT) for pituitary adenomas, including GH-secreting ones, frequently leads to GH deficiency (GHD). Data on the effects of surgery alone (S) on dynamic GH secretion are limited. The aim of the study was to investigate the occurrence of GHD in acromegalic patients treated with different therapeutic options.


METHODS
Fifty-six patients in remission from acromegaly, (33 F & 23 M, age: 54+/-13 years, body mass index (BMI): 28.4+/-4.1 kg/m(2), 21 with adequately substituted pituitary deficiencies) treated by S alone (n=33, group 1) or followed by RT (n=23, group 2), were investigated for GHD by GHRH plus arginine testing, using BMI-adjusted cut-offs. Several metabolic and cardiovascular parameters (waist circumference, body fat percentage, blood pressure, fasting and post-oral glucose tolerance test glucose, HbA1c, insulin resistance and lipid profile) were evaluated in all the patients and 28 control subjects with known diagnosis of GHD.


RESULTS
Serum GH peak after challenge was 8.0+/-9.7 microg/l, without any correlation with post-glucose GH nadir and IGF-1 levels. The GH response indicated severe GHD in 34 patients (61%) and partial GHD in 15 patients (27%). IGF-1 were below the normal range in 14 patients (25%). The frequency of GHD was similar in the two treatment groups (54% in group 1 and 70% in group 2). No significant differences in metabolic parameters were observed between acromegalic patients and controls with GHD.


CONCLUSIONS
Severe GHD may occur in about 60% of patients treated for acromegaly, even when cured after S alone. Thus, a stimulation test (i.e. GHRH plus arginine) is recommended in all cured acromegalic patients, independently from previous treatment.
Ronchi
C L
CL
Department of Medical Sciences, University of Milan, 20122 Milan, Italy. cristina.ronchi@unimi.it
Giavoli
C
C
Ferrante
E
E
Verrua
E
E
Bergamaschi
S
S
Ferrari
D I
DI
Corbetta
S
S
Montefusco
L
L
Arosio
M
M
Ambrosi
B
B
Spada
A
A
Beck-Peccoz
P
P
D000172:Acromegaly / Q000453:epidemiology* / Q000532:radiotherapy / Q000601:surgery; D000236:Adenoma / Q000453:epidemiology* / Q000532:radiotherapy / Q000601:surgery; D000328:Adult; D000368:Aged; D005260:Female; D005951:Glucose Tolerance Test; D019382:Human Growth Hormone / Q000097:blood / Q000172:deficiency*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000453:epidemiology* / Q000532:radiotherapy / Q000601:surgery; D011183:Postoperative Complications / Q000097:blood* / Q000175:diagnosis; D015995:Prevalence
D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I